DLL3 Polyclonal Antibody

This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene.

The DLL3 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of DLL3 protein expression in various biological samples. This antibody is produced using advanced recombinant technology, ensuring high affinity and sensitivity.

The DLL3 Polyclonal Antibody exhibits exceptional performance in immunohistochemistry (IHC), immunofluorescence (IF), and western blotting (WB) applications. It recognizes endogenous levels of DLL3 protein, making it an ideal choice for studying DLL3-related cellular processes and pathways.

With its superior specificity, this antibody enables accurate and precise identification of DLL3 protein in a wide range of species, including human, mouse, and rat. Its versatility allows for comprehensive research in diverse fields such as cancer biology, developmental biology, and neurobiology.

The DLL3 Polyclonal Antibody is supplied as a liquid formulation, ensuring ease of use and convenience. It is provided in a ready-to-use format, eliminating the need for time-consuming and complex preparation steps. The antibody is stable and long-lasting, guaranteeing consistent and reliable results over multiple experiments.

In summary, the DLL3 Polyclonal Antibody is a valuable tool for researchers seeking to investigate the role and function of DLL3 protein in various biological contexts. Its exceptional specificity, versatility, and ease of use make it an indispensable asset in advancing scientific knowledge and understanding.